FOSTAG Formenbau AG

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

FOSTAG Formenbau AG - overview

Established

1955

Location

Switzerland, -, Switzerland

Primary Industry

Materials

About

Based in Switzerland, and founded in 1955 by Bruno and Hans Segmuller, FOSTAG Formenbau AG, operates as an injection mould-making company that offers various injection moulds for medical plications. In April 2021, a consortium led by BLR & Partners acquired a majority stake in FOSTAG Formenbau AG from the company's management. As of 2024, the company is led by its CEO, Markus Mühlemann. The company offers various injection moulds used for medical, diagnostic, pharmaceutical, or specific special applications like blood filters, IV connectors, drip chambers, hubs, IV catheters, surgical sutures, disposable syringes, COC syringes, and many more.


The company also provides various planning, consulting, designing, and manufacturing services for materials such as COC, PVC, and more, along with qualification and training solutions.


Current Investors

BLR & Partners

Primary Industry

Materials

Sub Industries

Engineering, Education & Training Services, Biomaterials

Website

www.fostag.com/

Verticals

Manufacturing

Company Stage

Mature - Buyout

Total Amount Raised

Subscriber access only

FOSTAG Formenbau AG - deals

Deals TypeDeal StatusTarget (s)Deal DateInvestor(s)Seller(s)Deal size (Mn)Enterprise value (Mn)Post-money valuation (Mn)EBITDA multiple (x)Revenue multiple (x)Lead partner (s)
BuyoutCompletedFOSTAG Formenbau AG-

Displaying 1 - 1 of 1

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.